Vbl_Logo.png
VBL Therapeutics to Report Third Quarter Financial Results on November 15
November 08, 2021 08:00 ET | VBL Therapeutics
TEL AVIV, Israel and NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical stage company developing first-in-class therapeutics for difficult-to-treat malignant...
22157.jpg
Global $892 Mn Clinical Oncology Next Generation Sequencing Markets to 2028 by Technology (WGS, WES) & Application (Screening, Companion Diagnostics)
October 04, 2021 10:53 ET | Research and Markets
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Oncology Next Generation Sequencing Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global clinical...
Immunicum och University Medical Center Groningen erhåller bidrag från Health ~ Holland för fortsatt utveckling av vaccin mot canceråterfall vid äggstockscancer
September 08, 2021 02:00 ET | Immunicum AB
Pressmeddelande 8 september 2021 Immunicum och University Medical Center Groningen erhåller bidrag från Health ~ Holland för fortsatt utveckling av vaccin mot canceråterfall vid...
Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer
September 08, 2021 02:00 ET | Immunicum AB
Press Release 8 September 2021 Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer ...
THE NATIONAL OVARIAN CANCER COALITION (NOCC) TO HOST ITS ANNUAL TOGETHER IN TEAL® - EVERYWHERE AS ONE NATIONAL BROADCAST CELEBRATION DURING SEPTEMBER AWARENESS MONTH ON SATURDAY, SEPTEMBER 25, 2021
September 01, 2021 05:10 ET | National Ovarian Cancer Coalition
Dallas, TX, Sept. 01, 2021 (GLOBE NEWSWIRE) -- During Ovarian Cancer Awareness Month, The National Ovarian Cancer Coalition (NOCC) will host its National Broadcast Celebration on Saturday, September...
22157.jpg
Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics
August 20, 2021 06:08 ET | Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
20170406 Telix Logo.png
Telix Progresses Novel Lung and Ovarian Cancer Theranostic APOMAB®
August 16, 2021 20:03 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has extended its previously...
Logo.jpg
Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
July 19, 2021 08:00 ET | Celsion CORP
OVATION 2 Study is 50% Enrolled; Excellent R0 Surgical Resection Noted Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable Risk/Benefit When Administered Over a Six-Month...
Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer
June 23, 2021 02:00 ET | Immunicum AB
Press Release 23 June 2021 Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer - First study...
Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer
June 23, 2021 02:00 ET | Immunicum AB
Pressrelease 23 juni, 2021 Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer - Första studien för...